Crossmark

Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea

Crossref DOI link: https://doi.org/10.1186/s12885-022-09250-8

Published Online: 2022-02-08

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Han, Kyu-Tae

Kim, Seungju
License Information

Text and Data Mining valid from 2022-02-08

Version of Record valid from 2022-02-08
More Information

Article History

Received: 5 July 2021

Accepted: 27 January 2022

First Online: 8 February 2022

Declarations

:

: This study was conducted using secondary data, which are public data, and individuals were encrypted and could not be identified. According to the Bioethics and Safety Act, this study presents only the minimum risk. The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of the Catholic University of Korea (IRB number: MC21ENSI0043).

: Not applicable.

: None.

Document is current

Any future updates will be listed below